DENTSPLY International (NAS: XRAY) filed its 10-K on Feb. 24. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), DENTSPLY International beat expectations on revenues and missed slightly on earnings per share.
Compared to the prior-year quarter, revenue expanded significantly and GAAP earnings per share shrank significantly.
Margins contracted across the board.
DENTSPLY International booked revenue of $738.0 million. The 10 analysts polled by S&P Capital IQ expected to see revenue of $722.6 million on the same basis. GAAP reported sales were 30% higher than the prior-year quarter's $568.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $0.51. The 11 earnings estimates compiled by S&P Capital IQ predicted $0.52 per share on the same basis. GAAP EPS of $0.28 for Q4 were 40% lower than the prior-year quarter's $0.47 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 46.7%, 390 basis points worse than the prior-year quarter. Operating margin was 6.6%, 1,130 basis points worse than the prior-year quarter. Net margin was 5.5%, 640 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $716.0 million. On the bottom line, the average EPS estimate is $0.51.
Next year's average estimate for revenue is $2.97 billion. The average EPS estimate is $2.25.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 221 members out of 238 rating the stock outperform, and 17 members rating it underperform. Among 92 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 90 give DENTSPLY International a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on DENTSPLY International is outperform, with an average price target of $41.56.
The health-care investing landscape is littered with also-rans and a few major winners. Is DENTSPLY International the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.
Add DENTSPLY International to My Watchlist.
At the time thisarticle was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.